Click on headlines below to download research

Performance setback may provide an opportunity
The Biotech Growth Trust | 08/09/2021

The Biotech Growth Trust (BIOG) is managed by Geoff Hsu of OrbiMed Capital, which is a specialist healthcare investor with 11 offices across the globe…

Favourable industry fundamentals
The Biotech Growth Trust | 09/03/2021

The Biotech Growth Trust (BIOG) generated another year of positive absolute and relative performance in 2020. Manager Geoff Hsu of global specialist healthcare…

Firing on all cylinders
The Biotech Growth Trust | 10/08/2020

The Biotech Growth Trust (BIOG) is managed by Geoff Hsu, who is able to draw on the considerable resources of specialist healthcare investor OrbiMed Capital.…